Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Intervalo de año
1.
Acta cir. bras ; 33(5): 439-445, May 2018. graf
Artículo en Inglés | LILACS | ID: biblio-949344

RESUMEN

Abstract Purpose: To investigate the effects of capsiate treatment on hepatic hyperplasia in partially hepatectomized rats. Methods: The animals were divided into a Capsiate group (CPH), a Capsiate Post-Partial Hepatectomy group (CPPH) and a Partial Hepatectomy Control group (PH). CPH and CPPH animals received 60 mg/kg/day Capsiate for 30 days. Next, the rats underwent partial hepatectomy. CPPH animals continued to receive treatment for 48 h after partial hepatectomy. Liver tissue and intracardiac blood samples were obtained 24 or 48 h after PH. Results: Capsiate treatment interfered with hepatic parameters, reducing the number of mitoses and apoptosis and increasing blood ALT and alkaline phosphatase concentrations. Conclusion: Capsiate treatment preceding hepatic surgery may compromise the initial period of postoperative recovery.


Asunto(s)
Animales , Masculino , Ratas , Capsaicina/análogos & derivados , Hepatectomía , Hígado/enzimología , Aspartato Aminotransferasas/metabolismo , Capsaicina/farmacología , Ratas Wistar , Apoptosis/efectos de los fármacos , Alanina Transaminasa/metabolismo , Fosfatasa Alcalina/metabolismo , Hígado/efectos de los fármacos , Hígado/patología , Regeneración Hepática/efectos de los fármacos , Mitosis/efectos de los fármacos
2.
Acta cir. bras ; 32(3): 194-202, Mar. 2017. tab, graf
Artículo en Inglés | LILACS | ID: biblio-837694

RESUMEN

Abstract Purpose: To investigate the effects of lycopene and resveratrol pretreatment on hepatic hyperplasia in partially hepatectomized rats. Methods: The lycopene group and the resveratrol group received 40 mg/kg/day of lycopene or resveratrol, respectively (dissolved in olive oil or in saline solution, respectively) and administered via a gastric tube for 30 days. The partially hepatectomzed (PH) control groups received saline or olive oil via a gastric tube for 30 days, respectively, and the normal control group received no treatment. Liver tissue and intracardiac blood samples were obtained 24, 36 or 48 h after PH. Results: No areas of fibrosis were detected. No significant changes in mitotic index, in the number of apoptosis events or in aspartate aminotransferase and alanine aminotransferase levels were observed. Conclusions: Lycopene and resveratrol pretreatment did not interfere on hepatic hyperplasia in partially hepatectomized rats.


Asunto(s)
Animales , Masculino , Estilbenos/farmacología , Carotenoides/farmacología , Hepatectomía/métodos , Hígado/cirugía , Hígado/efectos de los fármacos , Antioxidantes/farmacología , Aspartato Aminotransferasas/sangre , Factores de Tiempo , Reproducibilidad de los Resultados , Resultado del Tratamiento , Ratas Wistar , Apoptosis/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Alanina Transaminasa/sangre , Hígado/enzimología , Hígado/patología , Regeneración Hepática/efectos de los fármacos , Índice Mitótico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA